The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer’s disease

被引:0
作者
Alice Jaillard
Matthieu Vanhoutte
Aurélien Maureille
Susanna Schraen
Emilie Skrobala
Xavier Delbeuck
Adeline Rollin-Sillaire
Florence Pasquier
Stéphanie Bombois
Franck Semah
机构
[1] CHU Lille,Nuclear Medicine Department
[2] Inserm,Neurology Department
[3] U1171,Department of Biology and Pathology
[4] CHU Lille,undefined
[5] CHU Lill,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词
FDG-PET; Alzheimer’s disease; CSF biomarkers;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:324 / 333
页数:9
相关论文
共 221 条
[1]  
Hansson O(2006)Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study Lancet Neurol 5 228-234
[2]  
Zetterberg H(2009)CSF biomarkers in relationship to cognitive profiles in Alzheimer disease Neurology 72 1056-1061
[3]  
Buchhave P(2010)CSF biomarkers predict a more malignant outcome in Alzheimer disease Neurology 74 1531-1537
[4]  
Londos E(2012)Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET Eur J Nucl Med Mol Imaging 39 990-1000
[5]  
Blennow K(2007)Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study Neurology 68 501-508
[6]  
Minthon L(2009)Relationships between biomarkers in aging and dementia Neurology 73 1193-1199
[7]  
van der Vlies AE(2015)Functional correlates of t-tau, p-tau and Aβ Nucl Med Commun 36 461-468
[8]  
Verwey NA(2013) amyloid cerebrospinal fluid levels in Alzheimer’s disease: a Neurobiol Dis 54 486-491
[9]  
Bouwman FH(2012)F-FDG PET/CT study Am J Alzheimers Dis Other Demen 27 413-420
[10]  
Blankenstein MA(2005)Exacerbated CSF abnormalities in younger patients with Alzheimer’s disease Brain 128 1790-1801